FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. (Q53189719)

12 May 2018

title

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. (English)

1 reference

12 May 2018

main subject

vascular calcification

1 reference

7

1 reference

12 May 2018

author name string

L Desjardins

1

1 reference

12 May 2018

S Liabeuf

2

1 reference

12 May 2018

C Renard

3

1 reference

12 May 2018

A Lenglet

4

1 reference

12 May 2018

H-D Lemke

5

1 reference

12 May 2018

G Choukroun

6

1 reference

12 May 2018

Z A Massy

8

1 reference

12 May 2018

European Uremic Toxin (EUTox) Work Group

9

1 reference

12 May 2018

language of work or name

English

0 references

publication date

23 November 2011

1 reference

12 May 2018

Osteoporosis International

published in

1 reference

12 May 2018

volume

23

1 reference

12 May 2018

page(s)

2017-2025

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00198-011-1838-0

exact match

0 references

cites work

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Chronic kidney disease as cause of cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Quantification of coronary artery calcium using ultrafast computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Genetic evidence of serum phosphate-independent functions of FGF-23 on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

21 January 2018

1 reference

12 December 2020

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice

1 reference

12 December 2020

Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness

1 reference

12 December 2020

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

12 December 2020

Klotho deficiency causes vascular calcification in chronic kidney disease

1 reference

12 December 2020

Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients

1 reference

12 December 2020

Total hip bone mass predicts survival in chronic hemodialysis patients

1 reference

12 December 2020

Pulse wave velocity and vascular calcification at different stages of chronic kidney disease

1 reference

12 December 2020

10.1007/S00198-011-1838-0

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

22109743

1 reference

12 May 2018